Inhibition of tolbutamide 4-methylhydroxylation by a series of non-steroidal anti-inflammatory drugs in V79-NH cells expressing human cytochrome P4502C10

References

• Back D. J., Tjia J. F., Karbwang J., Colbert J. In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines. British Journal of Clinical Pharmacology 1988; 26: 23–29
   PubMed Web of Science ®Google Scholar
• Brian W. R., Srivastava P. K., Umbenhauer D. R., Lloyd R. S., Guengerich F. P. Expression of a human liver cytochrome P450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. Biochemstry 1989; 28: 4993–4999
   PubMed Web of Science ®Google Scholar
• Crespi C. L., Gonzalez F. J., Steimel D. T., Turner T. R., Gelboin H. V., Penman B. W., Langenbach R. A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chemical Research in Toxicology 1991a; 4: 566–572
   PubMed Web of Science ®Google Scholar
• Crespi C. L., Penman B. W., Steimel D. T., Gelboin H. V., Gonzalez F. J. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin and comparison to CYP1A2 and CYP2A3. Carcinogenesis 1991b; 12: 355–359
   PubMed Web of Science ®Google Scholar
• De Groene E. M., Seinen W., Horbach G. J. M. J. A NIH/3T3 cell line stably expressing human cytochrome P450–3A4 used in combination with a lacZ' shuttle vector to study mutagenicity. European Journal of Pharmacology 1995; 293: 47–53
   PubMed Web of Science ®Google Scholar
• De Groene E. M., Hassing I. G. A. M., Blom M. J., Seinen W., Fink-Gremmels J., Horbach G. J. Development of human cytochrome P450-expressing cell lines: application in mutagenicity testing of ochratoxin A. Cancer Research 1996; 56: 299–304
   PubMed Web of Science ®Google Scholar
• Denizat F., Lang R. Rapid colorimetric assay for cell growth and survival. Journal of Immunological Methods 1986; 89: 271–277
   PubMed Web of Science ®Google Scholar
• Doehmer J., Dogra S., Friedberg T., Monier S., Adesnik M., Glatt H., Oesch F. Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin B1. Proceedings of the National Academy of Sciences, USA 1988; 85: 5769–5773
   PubMed Web of Science ®Google Scholar
• Dogra S., Doehmer J., Glatt H., Molders H., Siegert P., Friedberg T., Seidei A., Oesch F. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing. Molecular Pharmacology 1990; 37: 608–613
   PubMed Web of Science ®Google Scholar
• Ged C., Umbenhauer D. R., Bellew T. M., Bork R. W., Srivastava P. K., Shinriki N., Lloyd R. S., Guengerich F. P. Characterization of cDNA, mRNA's, and proteins related to human liver microsomal cytochrome P450 (s)-mephenytoin 4′-hydroxylase. Biochemistry 1988; 27: 6929–6940
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J. Human cytochromes P450: problems and prospects. Trends in Pharmacological Sciences 1992; 13: 346–352
   PubMed Web of Science ®Google Scholar
• Goldstein J. A., De Morais S. M. Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 1994; 6: 285–299
   Google Scholar
• Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456–467
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Characterization of human microsomal cytochrome P450 enzymes. Annual Review in Pharmacological Toxicology 1989a; 29: 241–264
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Polymorphism of cytochrome P-450 in humans. Trends in Pharmacological Sciences 1989b; 10: 107–109
   PubMed Web of Science ®Google Scholar
• Kiefer F., Wiebel F. J. V79 Chinese hamster cells express cytochrome P-450 activity after simultaneous exposure to polycyclic aromatic hydrocarbons and aminophylline. Toxicology Letters 1989; 48: 265–273
   PubMed Web of Science ®Google Scholar
• Knodell R. G., Hall S. D., Wilkinson G. R., Guengerich F. P. Hepatic metabolism of tolbutamide: characterization of the form of cytochrome-P450 involved in methyl hydroxylation and relationship to in vivo disposition. Journal of Pharmacological and Experimental Therapeutics 1987; 241: 1112–1119
   PubMed Web of Science ®Google Scholar
• Lehman T. D., Transon C., Bonnabry P., Dayer P. A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs. Drugs in Experimental Clinical Research 1993a; 19: 189–195
   Google Scholar
• Leeman T., Transon C., Dayer P. Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver. Life Sciences 1993b; 52: 29–34
   PubMedGoogle Scholar
• Miller A. D., Rosman G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980–990
   PubMed Web of Science ®Google Scholar
• Miners J. O., Smith K. J., Robson R. A., McManus M. E., Veronese M. E., Birkett D. J. Tolbutamide hydroxylation by human liver microsomes. Kinetic characterization and relationship to other cytochrome P-450 dependent xenobiotic oxidations. Biochemical Pharmacology 1988; 37: 1137–1144
   PubMed Web of Science ®Google Scholar
• Morel F., Beaune P. H., Ratanasavanh D., Flinois J. P., Yang C. S., Guengerich F. P., Guillouzo A. Expression of cytochrome P-450 enzymes in cultured human hepatocytes. European Journal of Biochemistry, 191: 437–444
   Google Scholar
• Rettie A. E., Korzekwa K. R., Kunze K. L., Lawrence R. F., Eddy A. C., Aoyama T., Gelboin H. V., Gonzalez F. J., Trager W. F. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chemical Research in Toxicology 1992; 5: 54–59
   PubMed Web of Science ®Google Scholar
• Rodrigues A. D., Kukula M. J., Roberts E. M., Quellet D., Rodger T. R. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes. Evidence for the involvement of cytochrome P4501A2 and P4502C9/10. Drug Metabolism and Disposition 1996; 24: 126–136
   PubMed Web of Science ®Google Scholar
• Tracy T. S., Rosenbluth B. W., Wrighton S. A., Gonzalez F. J., Korzekwa K. R. Role of cytochrome P450 2C9 and an allelic variant in the 4′-hydroxylation of (R)- and (S)-flurbiprofen. Biochemical Pharmacology 1995; 49: 1269–1275
   PubMed Web of Science ®Google Scholar
• Wiebel F. J., Kiefer F., Cumpelik O. Expression of monomorphic and polymorphic acetyltransferase in V79 cells differing in sensitivity to 1,6-dinitropyrene (1,6-DNP). Proceedings of the American Association for Cancer Research, Baltimore, 1992, M. Michal. Waverley Press Inc., 154, 20–23 March 1992, San Diego, CA, vol. 33, Abstract no. 923
   Google Scholar
• Zhao J., Leeman T., Dayer P. In vitro oxidation of oxicam NSAIDs by a human liver cytochrome P450. Life Sciences 1992; 51: 575–581
   PubMed Web of Science ®Google Scholar